These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Salivary and lacrimal gland dysfunction (sicca syndrome) after radioiodine therapy. Solans R, Bosch JA, Galofré P, Porta F, Roselló J, Selva-O'Callagan A, Vilardell M. J Nucl Med; 2001 May; 42(5):738-43. PubMed ID: 11337569 [Abstract] [Full Text] [Related]
23. Radioprotection of salivary glands by amifostine in high-dose radioiodine therapy. Bohuslavizki KH, Brenner W, Klutmann S, Hübner RH, Lassmann S, Feyerabend B, Lüttges J, Tinnemeyer S, Clausen M, Henze E. J Nucl Med; 1998 Jul; 39(7):1237-42. PubMed ID: 9669401 [Abstract] [Full Text] [Related]
24. Influence of vitamin C on salivary absorbed dose of 131I in thyroid cancer patients: a prospective, randomized, single-blind, controlled trial. Liu B, Kuang A, Huang R, Zhao Z, Zeng Y, Wang J, Tian R. J Nucl Med; 2010 Apr; 51(4):618-23. PubMed ID: 20237029 [Abstract] [Full Text] [Related]
25. [The interpretation of the 99mTcO-4-salivary gland scans (author's transl)]. Breunsbach J, Dvorák K. Fortschr Geb Rontgenstr Nuklearmed; 1974 Oct; 121(4):500-6. PubMed ID: 4373349 [No Abstract] [Full Text] [Related]
26. [Quantitative salivary gland scintigraphy--a recommended examination prior to and after radioiodine therapy]. Bohuslavizki KH, Brenner W, Lassmann S, Tinnemeyer S, Kalina S, Clausen M, Henze E. Nuklearmedizin; 1997 Apr; 36(3):103-9. PubMed ID: 9162904 [Abstract] [Full Text] [Related]
28. Effect of selenium supplementation for protection of salivary glands from iodine-131 radiation damage in patients with differentiated thyroid cancer. Son H, Lee SM, Yoon RG, Lee H, Lee I, Kim S, Chung WY, Lee JW. Hell J Nucl Med; 2017 Sep; 20(1):62-70. PubMed ID: 28315910 [Abstract] [Full Text] [Related]
30. Evidence for early and persistent impairment of salivary gland excretion after irradiation of head and neck tumours. Liem IH, Olmos RA, Balm AJ, Keus RB, van Tinteren H, Takes RP, Muller SH, Bruce AM, Hoefnagel CA, Hilgers FJ. Eur J Nucl Med; 1996 Nov; 23(11):1485-90. PubMed ID: 8854847 [Abstract] [Full Text] [Related]
31. A prospective study of salivary gland function in lymphoma patients receiving head and neck irradiation. Rodrigues NA, Killion L, Hickey G, Silver B, Martin C, Stevenson MA, Mauch PM, Ng AK. Int J Radiat Oncol Biol Phys; 2009 Nov 15; 75(4):1079-83. PubMed ID: 19327910 [Abstract] [Full Text] [Related]
32. Salivary gland protection by S-2-(3-aminopropylamino)-ethylphosphorothioic acid (amifostine) in high-dose radioiodine treatment: results obtained in a rabbit animal model and in a double-blind multi-arm trial. Bohuslavizki KH, Klutmann S, Jenicke L, Kröger S, Buchert R, Mester J, Clausen M. Cancer Biother Radiopharm; 1999 Oct 15; 14(5):337-47. PubMed ID: 10850318 [Abstract] [Full Text] [Related]
33. The influence of saliva flow stimulation on the absorbed radiation dose to the salivary glands during radioiodine therapy of thyroid cancer using 124I PET(/CT) imaging. Jentzen W, Balschuweit D, Schmitz J, Freudenberg L, Eising E, Hilbel T, Bockisch A, Stahl A. Eur J Nucl Med Mol Imaging; 2010 Dec 15; 37(12):2298-306. PubMed ID: 20625723 [Abstract] [Full Text] [Related]
34. Sialoendoscopic treatment for radioiodine induced sialadenitis. Kim JW, Han GS, Lee SH, Lee DY, Kim YM. Laryngoscope; 2007 Jan 15; 117(1):133-6. PubMed ID: 17202942 [Abstract] [Full Text] [Related]
35. [Radiation response and radiation effects in salivary glands (author's transl)]. Ernst H, Koppenhagen K, Ziegast J. Strahlentherapie; 1977 Jan 15; 153(1):9-12. PubMed ID: 835149 [Abstract] [Full Text] [Related]
36. Quantification of salivary gland function in thyroid cancer patients treated with radioiodine. Malpani BL, Samuel AM, Ray S. Int J Radiat Oncol Biol Phys; 1996 Jun 01; 35(3):535-40. PubMed ID: 8655377 [Abstract] [Full Text] [Related]
37. Salivary gland protection by amifostine in high-dose radioiodine treatment: results of a double-blind placebo-controlled study. Bohuslavizki KH, Klutmann S, Brenner W, Mester J, Henze E, Clausen M. J Clin Oncol; 1998 Nov 01; 16(11):3542-9. PubMed ID: 9817273 [Abstract] [Full Text] [Related]
38. Dose-volume modeling of salivary function in patients with head-and-neck cancer receiving radiotherapy. Blanco AI, Chao KS, El Naqa I, Franklin GE, Zakarian K, Vicic M, Deasy JO. Int J Radiat Oncol Biol Phys; 2005 Jul 15; 62(4):1055-69. PubMed ID: 15990009 [Abstract] [Full Text] [Related]
39. Assessment of salivary gland dysfunction after radioiodine therapy for thyroid carcinoma using non-contrast-enhanced CT: the significance of changes in volume and attenuation of the glands. Nabaa B, Takahashi K, Sasaki T, Okizaki A, Aburano T. AJNR Am J Neuroradiol; 2012 Nov 15; 33(10):1964-70. PubMed ID: 22555571 [Abstract] [Full Text] [Related]